Analyze Protein Structure with RedShiftBio’s AQS3pro at HOS 2019
RedShiftBio will be showcasing the AQS3pro at HOS 2019. We know time is tight at the conference, so why don’t you book a meeting in advance to see our protein characterization instrument?
Changes in the Higher Order Structure (HOS) of proteins can contribute to the quality attributes, and potentially safety, efficacy, and pharmacokinetic properties of protein therapeutics. There are many biophysical characterization methods and tools used in monitoring the attributes of protein therapeutics such as conformation and higher order structure. The 8th International Symposium on the Higher Order Structure of Protein Therapeutics in San Mateo, CA, April 8th-10th will highlight various biophysical methods for assessment of protein HOS, as well as the applications of the appropriate tools during the different stages of protein therapeutic development and biosimilarity assessments. A perfect place to see our Microfluidic Modulation Spectroscopy instrument.
The AQS3pro directly addresses the limitations of current technologies such as FTIR, and provides an efficient tool for direct, label-free protein analysis.
We will be presenting two posters:
Microfluidic Modulation Spectroscopy (MMS) Analysis of a Monoclonal Antibody From Low to High Concentrations and holding a Technical Seminar on Monday 8th on Monoclonal Antibody Analysis by Microfluidic Modulation Spectroscopy in a Complex Formulation Buffer (1 to 150 mg/mL)
Microfluidic Modulation Spectroscopy (MMS) - a novel automated infrared (IR) spectroscopic tool for secondary structure analysis of biopharmaceuticals with high sensitivity and repeatability.
Learn more about the Microfluidic Modulation Spectroscopy-based AQS3pro, which will be showcased at the conference